PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Maron, Bradley
TI  - Addition of Spironolactone to Ambrisentan May Be a Novel Treatment Strategy to Improve Outcome in Patients with PAH
DP  - 2013 Aug 01
TA  - MD Conference Express
PG  - 15--16
VI  - 13
IP  - 4
4099  - http://mdc.sagepub.com/content/13/4/15.2.short
4100  - http://mdc.sagepub.com/content/13/4/15.2.full
AB  - This article presents the results of a retrospective study that demonstrated a trend toward additional clinical improvement when spironolactone was added to ambrisentan for the treatment of patients with pulmonary arterial hypertension. This study analyzed data from patients in the double-blind, placebo-controlled Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension studies [ARIES-1 and −2; Galiè N et al. Circulation 2008].